In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it has enclosed the disclosure of Related Party Transactions on a consolidated basis, in the form at specified in the accounting standards for the half year ended 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.